Compute Health Acquisition announced that its stockholders approved the business combination with Allurion Technologies.
Nearly 99% of the votes cast, representing approximately 87.7% of Compute Health’s outstanding common stock, voted to approve the deal, including approximately 58.2% of the outstanding shares of Compute Health’s Class A common stock, which voted separately as a single class.
Allurion offers a weight-loss platform to help individuals overcome obesity.
The transaction is expected to close tomorrow. Allurion will list on the New York Stock Exchange, with stock and warrants trading under the new ticker symbols ALUR and ALUR WS.
No word on further redemptions, if any. The SPAC raised $750 million in a February 2021 IPO, but took a hit last December when redemptions reached 71% ahead of an extension vote.
As announced in February, the deal had an implied $500 million valuation.
The proposed transaction includes a fully committed PIPE led by RTW Investments and a non-dilutive, synthetic royalty financing from RTW Investments that will close concurrently with the business combination. Read more.
